3 ms·
Very unlikely, as the majority of those neoantigens are unique to the patient (that's why the vaccine has to be tailored for each of them).
by blackbear_ 3y ago
Very unlikely, as the majority of those neoantigens are unique to the patient (that's why the vaccine has to be tailored for each of them).
- loceng 3y agoAh yes, why patent specifics when you can patent the umbrella which is akin to covering all bases - https://patents.google.com/patent/US10055540B2/en https://patents.google.com/patent/US10055540B2/en
- blackbear_ 3y agoI'm not sure that patent is worth much to be honest. The general approach has been known and published in research circles for the better part of a decade before the patent was filed, and actually training a machine learning system in that way that gives usable predictions is still an open problem afaik.
- loceng 3y ago[flagged]